Fig 3.
Glycoprofiling of the consumption of fucosylated and acidic HMO by select B. breve strains. Consumption of eight fucosylated HMO (A) and 11 sialylated HMO (B) was calculated. B. longum subsp. infantis ATCC 15697 was included as a positive control. HMO consumption is represented as the percent difference in HMO between the start and the end of the exponential phase.